Initial Statement of Beneficial Ownership of Securities

This filing reports an initial statement of beneficial ownership of securities for ADIAL PHARMACEUTICALS, INC. (ADIL) by Coastlands Capital LP. The filing details holdings in common stock and pre-funded warrants. Coastlands Capital LP, through its general partners and related entities, holds 348,322 shares of common stock and 3,637,818 shares of common stock underlying pre-funded warrants. The pre-funded warrants have no expiration date and are exercisable, subject to a 4.99% beneficial ownership limitation. The filing includes an agreement regarding joint filing of statements among the reporting persons, with Coastlands Capital LP acting as their agent.